Cardio Diagnostics Holdings (CDIO) Prepaid Assets (2021 - 2026)
Cardio Diagnostics Holdings (CDIO) posted Prepaid Assets of $663320.0 for Q1 2026, down 17.29% sequentially from $801947.0 in Q4 2025, and down 20.77% YoY from $837222.0 in Q1 2025.
Cardio Diagnostics Holdings (CDIO) Prepaid Assets (2021 - 2026) Analysis & Trends
Cardio Diagnostics Holdings has reported Prepaid Assets for 6 years, with the latest figure at $663320.0 in Q1 2026.
- Quarterly Prepaid Assets fell 20.77% year-over-year to $663320.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $663320.0 (down 20.77% YoY) and the FY2025 annual result came in at $801947.0, down 15.11% from the prior year.
- Prepaid Assets slipped to $663320.0 in Q1 2026 per CDIO's latest filing, from $801947.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $1.8 million in Q4 2022 and troughed at $50371.0 in Q3 2022.
- A 5-year average of $836123.8 and a median of $820887.0 in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2024: Prepaid Assets soared 4338.78% in 2022, then sank 36.05% in 2024.
- Over 5 years, Prepaid Assets stood at $1.8 million in 2022, then decreased by 16.47% to $1.5 million in 2023, then sank by 36.05% to $944683.0 in 2024, then retreated by 15.11% to $801947.0 in 2025, then fell by 17.29% to $663320.0 in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $663320.0, $801947.0, and $561033.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cardio Diagnostics Holdings | 6.05 Mn | 460,682.10 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 569,357.00 |
| Mar 31, 2026 | 663,320.00 |
| Dec 31, 2025 | 801,947.00 |
| Sep 30, 2025 | 561,033.00 |
| Jun 30, 2025 | 723,921.00 |
| Mar 31, 2025 | 837,222.00 |
| Dec 31, 2024 | 944,683.00 |
| Sep 30, 2024 | 630,482.00 |
| Jun 30, 2024 | 820,887.00 |
| Mar 31, 2024 | 1.01 Mn |
| Dec 31, 2023 | 1.48 Mn |
| Sep 30, 2023 | 892,300.00 |
| Jun 30, 2023 | 1.21 Mn |
| Mar 31, 2023 | 1.43 Mn |
| Dec 31, 2022 | 1.77 Mn |
| Sep 30, 2022 | 50,371.00 |
| Jun 30, 2022 | 140,532.00 |
| Mar 31, 2022 | 255,095.00 |
| Dec 31, 2021 | 39,839.00 |